Assessment of Erythropoietin Efficacy in Treatment of Anemia in Pre-dialysis Chronic Kidney Disease Patients

Erythropoietin's Influence on Renal Anemia Treatment: Review Article

Effect of Increased Hemodialysis Time on the Response to Erythropoietin in Patients with End-Stage Renal Disease

Effect of HCV Infection Versus HBV Infection on the Response to Erythropoietin Therapy in The Treatment of Anemia in Prevalent Haemodialysis Patients

Evaluation of the efficacy of long acting erythropoietin versus short acting erythropoietin in the treatment of anemia in Egyptian patients under hemodialysis

Study of serum hepcidin level and its relation to recombinant human erythropoietin resistence, markers of iron status and C-reactive protein in patients with end stage renal dise

Comparing The Efficacy and Safety of (Ombitasvir/ Paritaprevir/ Ritonavir) in Management of Chronic HCV Patients Among Haemodialysis Patients and Those with Normal Renal Functions

HCV INFECTION AND ERYTHROPOIETIN IN HAEMODIALYSIS PATIENTS

EVALUATION OF THE ROLE OF HEPCIDIN IN PREDICTING THE THERAPEUTIC EFFICACY OF ERYTHROPOIESIS-STIMULATING AGENT TREATMENT IN PATIENTS OF CHRONIC RENAL FAILURE

Predictors of erythropoietin response in nondiabetic end-stage renal-disease patients on hemodialysis